Item

Efficacy and safety of avutometinib ± defactinib in recurrent low grade serous ovarian cancer: primary analysis of ENGOT-OV60/GOG-3052/RAMP 201

Banerjee, S.
Aghajanian, C.
Van Nieuwenhuysen, E.
Santin, A.
Ring, K.
Colombo, N.
Thaker, P.
Prendergast, E.
Moore, K.
Chon, H. S.
... show 10 more
Citations
Google Scholar:
Altmetric:
Abstract
Description
Date
2024
Publisher
Keywords
Type
Meetings and Proceedings
Citation
Banerjee S, Aghajanian C, Van Nieuwenhuysen E, Santin A, Ring K, Colombo N, et al. Efficacy and safety of avutometinib ± defactinib in recurrent low grade serous ovarian cancer: primary analysis of ENGOT-OV60/GOG-3052/RAMP 201. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2024 OCT;34(SUPPL_3):A13-A. PubMed PMID: WOS:001444792200025. English.
Journal Title
Journal ISSN
Volume Title
Embedded videos